BioSurface Technology Inc. sales and marketing update

BSRF posted sales of $1.3 million for the second quarter ended June 30 compared to $2.1 million in the 1992 quarter. The company attributed the results to a decline in sales of its Epicel-CEA epidermal grafts for permanent skin replacement. ...